1. Cenovus delivered a strong Q3 with upstream production exceeding expectations; 2. Downstream performance is still a drag, but management is addressing challenges; 3. The company's relative valuation is at a multi-year low, with an Overweight rating and a 84% upside to the $30/sh target.